Delivery Order SPE2DB24D2205-SPE2DB26FDSRZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count unit) with a ceiling value of $5,863.12. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by June 20, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a $9,508.89 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitive award, using firm fixed pricing, represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.09 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on July 9, 2025, with an ultimate completion date of July 10, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,040.74 for Carvedilol ER 10 mg capsules (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) valued at $2,663.43, with completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,363.06 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,963.74 on June 3, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and carries an ultimate completion date of June 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSRZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,974.72 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. This prime IDC vehicle enables comprehensive pharmaceutical support to military healthcare programs globally, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across DLA's Medical Supply Chain demonstrates the company's capability to fulfill federal pharmaceutical procurement requirements efficiently while supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 10/23/25 |